Grace Russell
An overview of SARS-CoV-2 (COVID-19) infection and the importance of molecular hydrogen as an adjunctive therapy
Russell, Grace; Rehman, Mubasher; LeBaron, Tyler W.; Veal, David; Adukwu, Emmanuel; Hancock, John
Authors
Mubasher Rehman
Tyler W. LeBaron
David Veal David.Veal@uwe.ac.uk
Senior Lecturer
Professor Emmanuel Adukwu Emmanuel.Adukwu@uwe.ac.uk
Deputy Head of School and Professor in Applied Microbiology
John Hancock John.Hancock@uwe.ac.uk
Professor in Cell Signalling
Abstract
SARS-CoV-2 is an emerging β-coronavirus that causes COVID-19 disease that manifests primarily as a pulmonary infection that can rapidly progress into severe and acute respiratory distress in susceptible patients. Initial reports of severe pulmonary infections first arose in December 2019 and were reported to the World Health Organization by the Wuhan Municipal Health Commission, China. Within months SARS-CoV-2 rapidly disseminated across the globe causing an unprecedented pandemic that has reached every inhabited continent and provoked an international response into research involving multiple disciplines to combat this novel contagion. Molecular hydrogen (H2) has shown potential as an emerging and effective therapy for numerous diseases, particularly those which involve excessive production of inflammatory agents as well as reactive oxygen/nitrogen species. Of pertinence to the investigations of SARS-CoV-2 infection are the increasing reports that suggest that H2 has therapeutic qualities in the treatment of chronic inflammatory lung conditions, and as such it is likely that this diatomic gas may alleviate the severe pulmonary symptoms of COVID-19. Here, the aim is to review the current research into SARS-CoV-2 and to better understand how treatment with molecular hydrogen is likely to affect cellular responses during SARS-CoV-2 infection.
Journal Article Type | Review |
---|---|
Acceptance Date | Jun 20, 2020 |
Online Publication Date | Jul 1, 2020 |
Publication Date | Jul 1, 2020 |
Deposit Date | Jun 21, 2020 |
Publicly Available Date | Aug 2, 2020 |
Journal | Reactive Oxygen Species |
Print ISSN | 2380-2367 |
Publisher | AIMSCI Cell Med Press |
Peer Reviewed | Peer Reviewed |
Volume | 10 |
Issue | 28 |
Pages | 150–165 |
Keywords | COVID-19; SARS-CoV-2; Cytokine Storm; Molecular Hydrogen; Reactive Oxygen Species; Virus |
Public URL | https://uwe-repository.worktribe.com/output/6050001 |
Publisher URL | https://aimsci.com/ros/index.php/ros/article/view/271 |
Files
Russell et al. H2-COVID revised ver
(554 Kb)
PDF
Licence
http://www.rioxx.net/licenses/all-rights-reserved
Publisher Licence URL
http://www.rioxx.net/licenses/all-rights-reserved
Russell Et Al. H2-COVID Revised Ver
(1.8 Mb)
Document
Licence
http://www.rioxx.net/licenses/all-rights-reserved
Publisher Licence URL
http://www.rioxx.net/licenses/all-rights-reserved
You might also like
Is glyceraldehyde-3-phosphate dehydrogenase a central redox mediator?
(2020)
Journal Article
Molecular hydrogen: Redox reactions and possible biological interactions
(2021)
Journal Article
Molecular hydrogen in agriculture
(2021)
Journal Article
How are turmeric and its derivative products beneficial for intestinal health?
(2022)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search